Pfizer Inc.
CDCP1-TARGETED THERAPIES
Last updated:
Abstract:
The present disclosure provides materials and methods for CUB domain-containing protein 1 (CDCP1)-targeted therapy.
Status:
Application
Type:
Utility
Filling date:
7 Nov 2019
Issue date:
21 Apr 2022